Antialbuminuric advantage of cilnidipine compared with L-type calcium channel blockers in type 2 diabetic patients with normoalbuminuria and microalbuminuria
- 15 February 2012
- journal article
- research article
- Published by Elsevier BV in Diabetes Research and Clinical Practice
- Vol. 97 (1), 91-98
- https://doi.org/10.1016/j.diabres.2012.01.024
Abstract
No abstract availableKeywords
Funding Information
- Grant-in-Aid for Scientific Research (23617018)
This publication has 21 references indexed in Scilit:
- Expression of N-type calcium channels in human adrenocortical cells and their contribution to corticosteroid synthesisHypertension Research, 2010
- Revised Equations for Estimated GFR From Serum Creatinine in JapanAmerican Journal of Kidney Diseases, 2009
- Different Effects of L/N-Type and L-Type Calcium Channel Blockers on the Renin-Angiotensin-Aldosterone System in SHR/IzmAmerican Journal of Nephrology, 2009
- Antiproteinuric effects of cilnidipineKidney International, 2008
- Aldosterone and progression of renal diseaseCurrent Opinion in Nephrology and Hypertension, 2008
- Renal and vascular protective effects of cilnidipine in patients with essential hypertensionJournal Of Hypertension, 2007
- The incidence and implications of aldosterone breakthroughNature Clinical Practice Nephrology, 2007
- Comparison between valsartan and valsartan plus cilnidipine in type II diabetics with normo- and microalbuminuriaKidney International, 2006
- Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2004)Hypertension Research, 2006
- Antiproteinuric Effect of an N-Type Calcium Channel Blocker, CilnidipineClinical and Experimental Hypertension, 2005